Publications by authors named "R A Wasmann"

Claim this Profile
F
Fixed-dose combination bictegravir-emtricitabine-tenofovir alafenamide twice-daily for treatment of HIV during rifampicin-based tuberculosis treatment (INSIGHT Study): a phase 2b, open-label, randomised non-comparative trial.
Anushka Naidoo, Kogieleum Naidoo, Marothi P Letsoalo, Roeland E Wasmann, Gillian Dorse

Lancet HIV· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of Twice-Daily Tenofovir Alafenamide In Adults with HIV-Associated TB on BIC/FTC/TAF and Rifampicin.
Emmanuella Chinonso Osuala, Ivan Nicholas Nkuhairwe, Marothi Peter Letsoalo, Kogieleum Naidoo, Rubeshan Perumal, Roeland E Wasmann

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous visual stimulus tracking to quantify eye motility in spinocerebellar ataxia type 3.
M J de Boer, R A Wasmann, J W R Pott, F W Cornelissen, N M Jansonius

Front Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Lufina Tsirizani, Hylke Waalewijn, Alexander Szubert, Veronica Mulenga, Chishala Chabala, Roeland E Wasmann

Antimicrob Agents Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Anne E M Kamphuis, Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Alexander Szubert

J Acquir Immune Defic Syndr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis